AVIR
Atea Pharmaceuticals Inc
Price:  
2.93 
USD
Volume:  
256,573.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atea Relative Valuation

-1819.2%
Upside

As of 2024-12-15, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (50.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.93 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -1819.2%.

The range of the Relative Valuation is (35.72) - (55.87) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.3x - 27.1x 24.0x
Forward P/E multiples 17.3x - 27.5x 24.9x
Fair Price (35.72) - (55.87) (50.37)
Upside -1319.3% - -2006.9% -1819.2%
2.93 USD
Stock Price
(50.37) USD
Fair Price

Atea Relative Valuation - Historical P/E Data

Date P/E
2024-11-29 -1.66
2024-11-27 -1.68
2024-11-26 -1.60
2024-11-25 -1.65
2024-11-22 -1.64
2024-11-21 -1.58
2024-11-20 -1.53
2024-11-19 -1.52
2024-11-18 -1.54
2024-11-15 -1.56
2024-11-14 -1.61
2024-11-13 -1.63
2024-11-12 -1.62
2024-11-11 -1.63
2024-11-08 -1.70
2024-11-07 -1.67
2024-11-06 -1.74
2024-11-05 -1.63
2024-11-04 -1.63
2024-11-01 -1.60
2024-10-31 -1.57
2024-10-30 -1.59
2024-10-29 -1.65
2024-10-28 -1.66
2024-10-25 -1.63
2024-10-24 -1.64
2024-10-23 -1.69
2024-10-22 -1.73
2024-10-21 -1.74
2024-10-18 -1.85
2024-10-17 -1.81
2024-10-16 -1.83
2024-10-15 -1.72
2024-10-14 -1.71
2024-10-11 -1.69
2024-10-10 -1.62
2024-10-09 -1.65
2024-10-08 -1.66
2024-10-07 -1.66
2024-10-04 -1.68
2024-10-03 -1.62
2024-10-02 -1.64
2024-10-01 -1.62
2024-09-30 -1.63
2024-09-27 -1.67
2024-09-26 -1.67
2024-09-25 -1.66
2024-09-24 -1.70
2024-09-23 -1.67
2024-09-20 -1.78